期刊文献+

法莫替丁肠溶片的血浓度测定及其在人体的药代动力学研究 被引量:3

High performance liquid chromatography determination of plasma famotidine and its use in pharmacokinetic study
下载PDF
导出
摘要 目的研究法莫替丁的血药浓度测定方法,并应用其进行法莫替丁片剂的人体药代动力学研究。方法采用固相萃取—高效液相色谱(HPLC)紫外检测法测定法莫替丁的血药浓度。18名健康男性志愿者,单剂量口服40mg法莫替丁片剂,不同时间点取静脉血,由血药浓度数据计算各自的主要药代动力学参数。结果所建立的血药浓度测定法能满足药代动力学实验要求。单次服用40mg法莫替丁片剂的主要药代动力学参数血药浓度-时间曲线下面积(AUC)0→12、AUC0→∞、Cmax、Tmax、T1/2分别为(882±185)、(912±187)ng·ml-1·h-1、(171±33)ng/ml、(2.3±0.4)和(2.6±2.7)h。结论法莫替丁的血药浓度测定方法简单、可靠。所得的药代动力学参数与国内外文献报道相似。 Objective To establish a high performance liquid chromatagraphy (HPLC) method for determining plasma famotidine concentration,and to use it for pharmcokinetic study.Methods Solid-phase extracting (SPE) was used for extracting famotidine from plasma and a HPLC-UV method was used.For pharmacokinetic study,a single dose of 40 mg famotidine was given to 18 healthy male volunteers.Blood samples were collected at different time spots.Results The pharmacokinetic parameters,AUC0→12,AUC0→∞,Cmax,Tmax and T1/2 ,in the volunteers after taking a single dose of 40 mg famotidine tablet was (882±185),(912±187) ng·ml-1·h-1,(171±33) ng/ml,(2.3±0.4) and (2.6±2.7) h,respectively.Conclusion The method is simple and reliable.The parameters obtained in this study are similar to those from domestic and overseas reports.
出处 《中国药物与临床》 CAS 2004年第5期353-355,共3页 Chinese Remedies & Clinics
关键词 法莫替丁 肠溶片 药代动力学 高压液相色谱法 血药浓度 色谱条件 Famotidine Chromatography,high pressure liquid Pharmacokinetics
  • 相关文献

参考文献4

  • 1[2]中华人民共和国药典委员会,编.中华人民共和国药典(第二部).北京:化学工业出版社,2000.424.
  • 2陈梅,许光炘,尹文记,王凯,王文铃,蔡志基.法莫替丁药代动力学研究[J].中国临床药理学杂志,1994,10(2):93-97. 被引量:7
  • 3[4]Zhong L, Yeh KC.Determination of famotidine in human plasma by high performance liquid chromatography with column switching.J Pharm Biomed Anal, 1998,16(6):1051-1057.
  • 4[5]Morgan MY,Stambuk D,Cottrell J,et al.Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver disease.Aliment Pharmacol Ther, 1990,4(1):83-96.

共引文献6

同被引文献19

  • 1高小玲,陈钧,胡凯莉,蒋新国.法莫替丁滴丸剂和片剂的人体生物等效性[J].中国临床药学杂志,2005,14(2):101-103. 被引量:3
  • 2王奇志,杜文民,朱光辉,王萍.法莫替丁不良反应的回顾性分析[J].中国新药与临床杂志,2005,24(7):582-585. 被引量:19
  • 3钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:580
  • 4IBRAHLM A,DARWISH,SAMIHA A,et al.Spectrophotometric determination of H2-receptor antagonists via their oxidation with cerium(Ⅳ)[J].Spectrochimica Acta Part A,2008.69(1):33-40.
  • 5ZARGHI A, SHAFAATI A, FOROUTAN SM ,et al. Development of a rapid HPLC method for determination of famotidinein human plasma using a monolithic column [ J ]. J Pharm Biomed Anal, 2005,39(34) : 677 -680.
  • 6DIANE AI. ASHIRU, RAJESH P, et al. Simple and universal HPLC-UV melhod to determine cimelidine, ranitidine, famotidine and mzatidine in urine: application to Ihe analysis of ranitidine and its metaboliles in human volunteers[J]. J Chromatogr B,2007,860(2):235 -240.
  • 7DOWLING TC,FRYE RF. Determination of famotidine in human plasma and urine by high-performance liquid chromatography [J].J Chromatogr B Sci Appl, 1999,732( 1 ) :239-243.
  • 8ZARGHI A, SHAFAATI A, FOROUTAN SM, et al. Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column[J]. J Pharm Biomed Anal,2005,39 (3-4) :677-680.
  • 9CAMPANERO MA, BUENO I,ARANGOA MA, et al. Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionization mass spectrometry. Illustration using an assay method for the determination of famotidine in human plasma[J]. J Chromatogr B Biomed Sci Appl,2001,763 (1-2) :21-33.
  • 10Largtry H, Grant S, Goa K. Famotidine-an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases[J].Drugs, 1989, 38(4): 551-590.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部